Item 2.01 Completion of Acquisition of Disposition of Assets.
As previously reported, on January 7, 2021, Acadia Healthcare Company, Inc., a
Delaware corporation (the "Company"), entered into a Share Purchase Agreement
(the "SPA") with RemedcoUK Limited, a company organized under the laws of
England and Wales and owned by funds managed or advised by Waterland Private
Equity Fund VII (the "Purchaser"), relating to the acquisition by the Purchaser
from the Company of all of the securities (the "Shares") issued by AHC-WW Jersey
Limited, a private limited liability company incorporated in Jersey and a
subsidiary of the Company, which constitutes the entirety of the Company's U.K.
business operations, operated under the Company's Priory Group business (the
"Transaction").
On January 19, 2021, the Company completed the Transaction. The purchase price
was approximately £1,078 million. The Company received proceeds of approximately
$1,350 million, net of transaction costs and the settlement of existing foreign
currency hedging liabilities and based on the current GBP/USD exchange rate.
Item 9.01 Financial Statements and Exhibits
(b) Pro Forma Financial Information.
The Company's unaudited pro forma condensed consolidated financial statements
giving effect to the Transaction are filed as Exhibit 99.1 hereto and are
incorporated by reference herein.
(c) Exhibits
Exhibit
No. Description
99.1 Acadia Healthcare Company, Inc. Unaudited Pro Forma Condensed
Consolidated Financial Statements.
104 Cover Page Interactive Data (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses